BioTime Inc. | Mutual Funds
Mutual Funds that own BioTime Inc.
Vanguard Total Stock Market Index Fund
2,329,213
1.84%
0
0%
07/31/2018
iShares Russell 2000 ETF
1,874,095
1.48%
-1,002
0.01%
09/06/2018
Vanguard Extended Market Index Fund
1,567,440
1.24%
0
0.01%
07/31/2018
British & American Investment Trust Plc (Top 20 Holdings)
1,525,776
1.2%
55,694
11.03%
12/31/2017
AXA Framlington Biotech Fund
1,077,106
0.85%
1,077,106
0.42%
02/28/2018
AXA Framlington Health Fund
1,032,369
0.81%
0
0.4%
04/30/2018
823,910
0.65%
0
0.44%
09/05/2018
iShares Russell 2000 Value ETF
624,127
0.49%
0
0.02%
09/06/2018
Fidelity Spartan Extended Market Index Fund
571,875
0.45%
0
0.01%
07/31/2018
Lincoln VIP - SSgA Small Mid Cap 200 Fund
535,063
0.42%
535,063
0.36%
03/31/2018
| Address |
1010 Atlantic Avenue
Alameda California 94501
United States
|
|
Employees
|
- |
| Website |
http://www.biotimeinc.com |
| Updated |
07/08/2019 |
| BioTime, Inc. is a clinical-stage biotechnology company, which deals with degenerative diseases. The company's programs are based on two core proprietary technology platforms: cell replacement and cell and drug delivery. Its cell replacement platform creates new cells and tissues with its pluripotent and progenitor cell technologies. |
